The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.14BCNY
917.05M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue (TTM)
5.73BCNY
855.72M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
-29.64%
vs Conglomerates peers
Updated Sep 22, 2026
Beta
0.6210x
vs all stocks
Updated Sep 22, 2026
52-Week Change
-1.55%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
6.14BCNY
917.05M · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
32.10BCNY
4.79B · vs all stocks (USD)
Updated Sep 22, 2026
Price to Sales (TTM)
1.09x
vs Conglomerates peers
Updated Sep 22, 2026
Price to Book (MRQ)
14.51x
vs Conglomerates peers
Updated Sep 22, 2026
Enterprise to Revenue
5.60x
vs Conglomerates peers
Updated Sep 22, 2026
Gross Margin
24.57%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 21.65%.Updated Sep 22, 2026
Profit Margin
-29.64%
vs Conglomerates peers
Updated Sep 22, 2026
Operating Margin
-7.67%
vs Conglomerates peers
Updated Sep 22, 2026
Return on Assets (TTM)
-0.96%
vs Conglomerates peers
Updated Sep 22, 2026
Return on Equity (TTM)
-180.09%
vs Conglomerates peers
Updated Sep 22, 2026
Revenue (TTM)
5.73BCNY
855.72M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
1.79CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
-24.80%
vs Conglomerates peers
Updated Sep 22, 2026
Gross Profit (TTM)
1.24BCNY
185.25M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
887.94MCNY
132.60M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
-1.70BCNY
-253.65M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
-24.84%
vs Conglomerates peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
841.25MCNY
125.62M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
384.27MCNY
57.38M · vs all stocks (USD)
Updated Sep 22, 2026
5-Year Average Dividend Yield
1.85%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Sep 22, 2026
Minority Interest (Equity)
161.16MCNYFY2025 · Dec 31, 2025
Revenue
6.36BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
4.88BCNYFY2025 · Dec 31, 2025
Gross Profit
1.48BCNYFY2025 · Dec 31, 2025
Operating Income
-392.23MCNY
-58.57M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-2.59BCNYFY2025 · Dec 31, 2025
Income Tax Expense
-128.77MCNYFY2025 · Dec 31, 2025
Net Income
-2.46BCNYFY2025 · Dec 31, 2025
EBIT
-755.17MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
887.94MCNYFY2025 · Dec 31, 2025
Research & Development
118.96MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
576.57MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
129.74MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.53MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.84BCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.6300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.24BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.24BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-2.46BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
421.04MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
472.51MCNYFY2025 · Dec 31, 2025
Free Cash Flow
412.11MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
422.04MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-2.46BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.92BCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
1.14BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-123.07MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-60.40MCNYFY2025 · Dec 31, 2025
Net Acquisitions
23.91MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
211.61MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
173.12MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
48.56BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-47.55BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.37BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-380.00MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-743.20MCNYFY2025 · Dec 31, 2025
Shares Outstanding
3.23BSharesUpdated Sep 22, 2026
Float Shares
2.39BSharesUpdated Sep 22, 2026
% Held by Insiders
36.24%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
4.27%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
4.48BCNY
669.38M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
1.39CNYUpdated Sep 22, 2026
Total Debt (MRQ)
30.42BCNY
4.54B · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
789.66x
vs Conglomerates peers
Updated Sep 22, 2026
Current Ratio (MRQ)
0.7990x
vs Conglomerates peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
0.1330CNYUpdated Sep 22, 2026
Total Assets
40.17BCNY
6.00B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
21.57BCNYFY2025 · Dec 31, 2025
Total Liabilities
39.39BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
18.60BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
6.63BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
32.75BCNYFY2025 · Dec 31, 2025
Cash
577.66MCNYFY2025 · Dec 31, 2025
Cash Equivalents
468.16MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.05BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
4.16BCNYFY2025 · Dec 31, 2025
Accounts Receivable
4.17BCNYFY2025 · Dec 31, 2025
Inventory
8.53BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.55BCNYFY2025 · Dec 31, 2025
Short-term Debt
25.00BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
111.43MCNYFY2025 · Dec 31, 2025
Long-term Debt
6.02BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
158.58MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
3.23BCNYFY2025 · Dec 31, 2025
Retained Earnings
-11.38BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
780.14MCNY
116.50M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
4.00MCNYFY2025 · Dec 31, 2025
52-Week Low
1.30CNYUpdated Sep 22, 2026
52-Week High
2.47CNYUpdated Sep 22, 2026
52-Week Change
-1.55%
vs all stocks
Updated Sep 22, 2026
Beta
0.6210x
vs all stocks
Updated Sep 22, 2026
50-Day MA
1.86CNYUpdated Sep 22, 2026
200-Day MA
1.73CNYUpdated Sep 22, 2026
Avg 10-Day Volume
141.59MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
207.80MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
-0.5300CNYUpdated Sep 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -29.6%, lower than 95% of its Conglomerates peers (median 4.7%)Significant